VX is dangerous because it disrupts nerve signalling and can cause life-threatening effects. It is a human-made nerve agent listed in Schedule 1 of the Chemical Weapons Convention. The convention listing identifies the agent’s classification, while its effects on nerve signalling explain the medical significance of an exposure.
VX inhibits acetylcholinesterase and drives uncontrolled acetylcholine activity, disrupting normal nerve signalling. The effects can include seizures, paralysis and respiratory failure. The mechanism and effects answer consecutive parts of the danger. Inhibition identifies the disruption to normal nerve signalling; seizures, paralysis and respiratory failure are possible consequences of that disruption. Their severity is why the change in nerve signalling can become life-threatening.
Physical form and exposure pattern
VX is a very low-volatility oily liquid. That description concerns the physical form of the agent. “Very low volatility” and “oily liquid” are both parts of that physical description; neither fixes the dose or route in a particular exposure. The physical form sits alongside the separate facts about what determines the severity and timing of effects in an exposed person.
Severity and onset vary with dose and route. Dose concerns the amount involved in an exposure, while route concerns the way exposure occurs. Both bear on how severe the effects become and when they appear, making dose and route central to understanding a particular exposure.
Skin exposure has a particular timing implication because dermal effects can be delayed for hours. The delay concerns when effects become apparent after that route of exposure. A person’s early appearance may therefore give an incomplete picture of what will follow, even though no immediate effect is yet visible.
Prompt trained care after exposure
Prompt trained decontamination and medical care are important after exposure, and antidotes exist. These points belong together in a trained response. Decontamination addresses the exposure, medical care addresses the effects on the exposed person, and antidote availability forms part of that medical context. Together they explain why the response should be prompt and handled by trained professionals.
The variable onset and the possibility of delayed dermal effects give that urgency practical force. A skin exposure may show no immediate effect and still produce effects hours later. Prompt trained attention therefore follows from the delay itself, together with the fact that severity and onset vary with dose and route.
